RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: ankylosing spondylitis
Accession: DOID:7147
browse the term
Definition: An arthritis that results_in inflammation in the joints of the spine and pelvis. The disease has_symptom pain, has_symptom stiffness in the spine, has_symptom stiffness in the neck, has_symptom stiffness in the hips, has_symptom stiffness in the jaw and has_symptom stiffness in the rib cage. (DO)
Synonyms: exact_synonym: Bechterew Disease; Bechterew syndrome; Bechterew's disease; Bechterews disease; Bekhterev syndrome; Bekhterev's disease; Marie Struempell disease; Marie Strumpell spondylitis; Marie-Strumpell disease; ankylosing spondylarthritides; ankylosing spondylarthritis; ankylosing spondyloarthritides; ankylosing spondyloarthritis; rheumatoid spondylitis; spondylarthritis ankylopoietica; spondylitis ankylopoietica; spondyloarthritis ankylopoietica
related_synonym: ankylosing spondylitis, susceptibility to
primary_id: MESH:D013167
xref: EFO:0003898 ; GARD:9518 ; ICD10CM:M45 ; ICD9CM:720.0 ; MIM:PS106300 ; NCI:C84564 ; ORDO:825
For additional species annotation, visit the
Alliance of Genome Resources .
G
Ace
angiotensin I converting enzyme
susceptibility
ISO
DNA:deletion:intron:IVS16+1464-1751del (human)
RGD
PMID:22876137
RGD:7829800
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:serum
RGD
PMID:21122270
RGD:5686891
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Ano6
anoctamin 6
severity
ISO
DNA:SNP: :rs17095830(human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22138694 PMID:23308121
RGD:9684849
NCBI chr15:95,688,724...95,873,353
Ensembl chr15:95,688,724...95,872,632
G
Antxr2
anthrax toxin receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20062062 PMID:21743469
NCBI chr 5:98,032,547...98,178,876
Ensembl chr 5:98,030,642...98,178,902
G
Aspn
asporin
susceptibility
ISO
DNA:repeats:exon:
RGD
PMID:20144272
RGD:9684964
NCBI chr13:49,697,919...49,721,041
Ensembl chr13:49,697,919...49,721,041
G
Card9
caspase recruitment domain family, member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21743469
NCBI chr 2:26,242,199...26,250,957
Ensembl chr 2:26,242,188...26,250,930
G
Crp
C-reactive protein, pentraxin-related
disease_progression
ISO
protein:increased expression:serum:
RGD
PMID:22422197 PMID:6605119
RGD:6482308 , RGD:9491788
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
ISO
DNA:polymorphism: :4887C>A (human)
RGD
PMID:12880680
RGD:1581252
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Erap1
endoplasmic reticulum aminopeptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17952073 PMID:20062062 PMID:21743469 PMID:23291587
NCBI chr13:74,787,692...74,841,321
Ensembl chr13:74,787,687...74,841,320
G
Fcgr4
Fc receptor, IgG, low affinity IV
severity
ISO
protein:decreased expression:polymorphonuclear leucocyte
RGD
PMID:8453794
RGD:5508388
NCBI chr 1:170,846,495...170,857,330
Ensembl chr 1:170,846,489...170,857,330
G
H2-Aa
histocompatibility 2, class II antigen A, alpha
severity
ISO
DNA:polymorphism:cds:HLA-DQA1*0401 (human)
RGD
PMID:19565552
RGD:5147611
NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797
G
H2-Ab1
histocompatibility 2, class II antigen A, beta 1
severity
ISO
DNA:polymorphism:cds:HLA-DQB1*0603 (human)
RGD
PMID:19565552
RGD:5147611
NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393
G
H2-Eb1
histocompatibility 2, class II antigen E beta
severity
ISO
DNA:polymorphisms:cds:HLA-DRB1*0801, HLA-DRB1*0804 (human)
RGD
PMID:19565552
RGD:5147611
NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648
G
H2-M2
histocompatibility 2, M region locus 2
no_association susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism:cds:HLA-B2705 (human) DNA:polymorphisms:cds:HLA-B27, HLA-B60 (human, Caucasian)
CTD RGD
PMID:8053961 PMID:8733445 PMID:21743469 PMID:21927904 PMID:22138694
RGD:10755579 RGD:7364914
NCBI chr17:37,791,742...37,794,445
Ensembl chr17:37,791,742...37,794,443
G
H2-Q4
histocompatibility 2, Q region locus 4
susceptibility
ISO
DNA:polymorphisms:cds:HLA-B27, HLA-B60 (human, Caucasian)
RGD
PMID:8733445
RGD:7364914
NCBI chr17:35,598,593...35,603,650
Ensembl chr17:35,598,593...35,604,266
G
Igfbp3
insulin-like growth factor binding protein 3
ISO
protein:decreased expression:serum
RGD
PMID:9851264
RGD:10402573
NCBI chr11:7,156,086...7,165,498
Ensembl chr11:7,156,086...7,163,923
G
Il12b
interleukin 12b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21743469
NCBI chr11:44,290,890...44,305,504
Ensembl chr11:44,290,890...44,304,860
G
Il17a
interleukin 17A
treatment
ISO
RGD
PMID:24035250
RGD:9068448
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
G
Il1r2
interleukin 1 receptor, type II
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20062062
NCBI chr 1:40,123,872...40,164,390
Ensembl chr 1:40,113,239...40,164,391
G
Il23r
interleukin 23 receptor
no_association
ISO
DNA:SNPs,haplotype:multiple: DNA:SNP: :rs11209026(human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17952073 PMID:20062062 PMID:19522770 PMID:19877036
RGD:8549549 , RGD:8549630
NCBI chr 6:67,399,906...67,468,838
Ensembl chr 6:67,399,916...67,468,839
G
Il6
interleukin 6
ISO
protein:increased expression:serum:
RGD
PMID:26339141
RGD:12792209
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Irak1
interleukin-1 receptor-associated kinase 1
susceptibility
ISO
DNA:SNP:enhancer: (rs3027898) (human)
RGD
PMID:20500689
RGD:7495783
NCBI chr X:73,057,520...73,067,527
Ensembl chr X:73,057,520...73,067,524
G
Jak2
Janus kinase 2
susceptibility
ISO
DNA:SNPs, haplotype:introns: (rs1536798, rs10119004, rs7857730) (human)
RGD
PMID:20627814
RGD:6483025
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
G
Kdm5a
lysine demethylase 5A
susceptibility
ISO
DNA:snps:intron:IVST>A, IVS-1467C>T, IVS+828T>C (rs7134353, rs2284336, rs11062357) (human)
RGD
PMID:24069348
RGD:9588532
NCBI chr 6:120,341,060...120,421,535
Ensembl chr 6:120,341,085...120,421,535
G
Mthfr
methylenetetrahydrofolate reductase
susceptibility
ISO
DNA:SNP:cds:677C>T (human)
RGD
PMID:25060515
RGD:42722610
NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
G
Pgf
placental growth factor
ISO
RGD
PMID:21873332
RGD:6483576
NCBI chr12:85,213,413...85,224,087
Ensembl chr12:85,213,409...85,224,564
G
Psmb9
proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2)
ISO
DNA: snp: rs17587
RGD
PMID:22034108
RGD:6483349
NCBI chr17:34,401,006...34,406,347
Ensembl chr17:34,400,961...34,406,738
G
Ptger4
prostaglandin E receptor 4 (subtype EP4)
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21743469 PMID:21743469
RGD:6483530
NCBI chr15:5,262,880...5,273,668
Ensembl chr15:5,236,142...5,273,668
G
Runx3
runt related transcription factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21743469
NCBI chr 4:134,847,956...134,905,301
Ensembl chr 4:134,847,963...134,905,301
G
Tap1
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
ISO
DNA:SNPs: :
RGD
PMID:19480848
RGD:6482250
NCBI chr17:34,406,530...34,416,199
Ensembl chr17:34,406,527...34,416,199
G
Tap2
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
ISO
DNA:SNPs: :
RGD
PMID:19480848
RGD:6482250
NCBI chr17:34,423,453...34,435,295
Ensembl chr17:34,422,501...34,435,295
G
Tbkbp1
TBK1 binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21743469
NCBI chr11:97,026,997...97,042,332
Ensembl chr11:97,026,997...97,042,321
G
Thbd
thrombomodulin
ISO
protein:increased expression:serum
RGD
PMID:21556780
RGD:5684983
NCBI chr 2:148,246,391...148,250,108
Ensembl chr 2:148,246,386...148,250,108
G
Tlr4
toll-like receptor 4
ISO
mRNA:increased expression:blood cell:
RGD
PMID:20952467
RGD:7794744
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tlr5
toll-like receptor 5
ISO
mRNA:increased expression:blood cell:
RGD
PMID:20952467
RGD:7794744
NCBI chr 1:182,782,317...182,804,010
Ensembl chr 1:182,782,353...182,804,010
G
Tnfrsf1b
tumor necrosis factor receptor superfamily, member 1b
ISO
RGD
PMID:21317434
RGD:5131280
NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440
G
Vip
vasoactive intestinal polypeptide
ISO
protein:increased expression:plasma
RGD
PMID:20340024
RGD:5685387
NCBI chr10:5,589,131...5,597,617
Ensembl chr10:5,589,218...5,597,617
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all